>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
急性冠脉综合征患者血浆脂质过氧化物升高及意义
作者:冯毅 王积慧 沈成兴 马根山 
单位:东南大学附属中大医院,心内科,江苏,南京,210009
关键词:急性冠脉综合征 脂质过氧化物 丙二醛 晚期蛋白氧化产物 氧化应激 
分类号:R542.22, R541.4
出版年·卷·期(页码):2007·26·第二期(98-101)
摘要:

目的:通过检测急性冠脉综合征(ACS)患者体内脂质过氧化物丙二醛(MDA)、晚期蛋白氧化产物(AOPP)的水平来探讨氧化应激损伤与ACS发生发展的关系. 方法:入选73例急性心肌梗死(AMI) [包括46例择期行经皮冠脉成形术(PCI) 和27例行急诊PCI患者]、49例不稳定性心绞痛(UA)及21例非冠心病患者,均经冠脉造影证实.于入院即刻、24h和48h采集外周静脉血标本.硫代巴比妥分光光度法测定MDA浓度;紫外荧光光度法测定AOPP浓度.结果:与非冠心病组对应各时间点比较,AMI择期PCI组、AMI急诊PCI组MDA浓度明显升高(P<0.05);非冠心病组MDA浓度与UA组比较无统计学差异.AMI择期PCI组、AMI急诊PCI组及UA组与非冠心病组比较,各时间点AOPP浓度明显升高(P<0.05);AMI择期PCI组各时间点AOPP浓度较AMI急诊PCI组高(P<0.01).结论:AMI患者血浆中MDA浓度显著升高,氧化应激产生的脂质过氧化过程可能是ACS病理生理发生发展中的重要环节.

Objective To examine the malondialdehyde(MDA) and advanced oxidation protein products(AOPP) in patients with acute coronary syndrome(ACS) and discuss the relationship between lipid peroxidate with the development of ACS.Methods The collected 73 patients with acute myocardial infarction(AMI)(including 46 selective PCI patients & 27 emergency PCI patients),49 patients with unstable angina pectoris(UA) and 21 patients with non-coronary artery disease(non-CAD) all underwent coronary angiography.Plasma were collected at immediately,post-24 hours and post-48 hours after patients were recruited.MDA was measured with TBA methods and AOPP was determined by measurements of optical density via spectrophotometry.Results Compared with normal group(non-CAD),significantly higher plasma MDA were seen in all patients with AMI(P<0.05),including selective PCI and emergency PCI patients,but it had no difference between the patients with UA and patients with non-CAD(P>0.05).Compared with normal group(non-CAD),significantly higher plasma AOPP were detected in the patients with AMI(including selective PCI and emergency PCI group)& UA(P<0.05).Comparing emergency PCI group,significantly higher plasma AOPP also existed in the selective PCI group(P<0.01).Conclusion Lipid peroxidation significantly increases in patients with AMI and it may have important effects in development of ACS.

参考文献:

[1] KAMINENI R, ALPERT J S. Acute coronary syndromes:initial evaluation and risk stratification. 2004(5). doi:10.1016/j.pcad.2003.12.002
[2] ROSS R. Atherosclerosis-an inflammatory disease (see comments). 1999(2). doi:10.1056/NEJM199901143400207
[3] ZHANG R, BRENNUM M L, FU X. Association between myeloperoxidase levels and risk of coronary artery disease. 2001(17). doi:10.1001/jama.286.17.2136
[4] SELJELFLOT I, ASE O, EID H. Levels of oxidative stress are associated with C-protein levels in patients with stable and unstable angina, 2002
[5] 郭志坚, 侯凡凡, 刘尚喜. 糖化和氧化产物修饰的蛋白质促进兔主动脉粥样斑块形成. 北京大学学报(医学版)2004(2)
[6] POLLACK C V, ROE M T, PETERSON E D. 2002 update to the ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction:implications for emergency department practice. 2003(3). doi:10.1067/mem.2003.88
[7] HOLVOET P, VANHAECKE J, JANSSENS S. Oxidized LDL and malondialdialdehyde modified LDL in patients with ACS and stable coronary artery disease, 1998
[8] SKVARILOVA M, BULAVA A, STEJSKAL D. Increased level of advanced oxidation protein products as a marker of oxidative stress in patients with acute coronary syndrome, 2005
[9] STRINGER M D, GEORGE P G, FREEMAN A. Lipid peroxidies and atherosclerosis, 1989(4)
[10] KANEDA H, TAGUCHI J, OGASAVARA K. Increased level of advanced oxidation protein products in patients with coronary artery disease, 2002
[11] ALBERT A W. Lipid hydroperoxide generation,turnover,and effector action in biological systems. 1998(8)
[12] MUTLU-TURKOGLU U, AKALIN Z, ILHAN E. Increased plasma malondialdehyde and protein carbonyl levels and lymphocyte DNA damage in patients with angiographically defined coronary artery disease. 2005(12). doi:10.1016/j.clinbiochem.2005.07.001
[13] IQBAL K, RAUOOF M A, MIR M M. Lipid peroxidation during acute coronary syndromes and its intensification at the time of myocardial ischemia reperfusion, 2002(3)
[14] DALLE-DONNE I, ROSSI R, GIUSTARINI D. Protein carbonyl groups as biomarkers of oxidative stress. 2003(1-2). doi:10.1016/S0009-8981(3)00003-2

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 411635 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-83272481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364